Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106978368B details a novel nitrilase biocatalysis route for L-glufosinate precursors, offering high optical purity and reduced environmental impact for agrochemical manufacturing.
Novel alkaline hydrolysis method for Afatinib degradation impurity ensuring high purity and supply chain reliability for pharmaceutical quality control.
Discover a novel bromfenac sodium synthesis method avoiding indole impurities. Enhanced purity, stable pH, and scalable production for pharmaceutical supply chains.
Novel LiOH and DMSO hydrolysis method ensures high purity Bempedoic acid intermediate with reduced safety risks and scalable production capabilities for global supply chains.
Patent CN116396950B reveals novel carboxylesterase mutants for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN108546720B reveals a green lipase-catalyzed route for Indobufen intermediates, offering high optical purity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN121472200A reveals high-efficiency nitrilase mutant for chiral acid synthesis. Offers green manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN1612880A details a streamlined synthesis of phenserine from physostigmine salts, offering high purity and yield for Alzheimer's drug manufacturing.
Patent CN114075258B reveals a novel iodine-free route for hydrocortisone production, offering superior purity over 99.5% and streamlined manufacturing for global supply chains.
Patent CN107641622B reveals efficient enzymatic hydrolysis of terephthalonitrile, offering cost reduction in pharmaceutical intermediate manufacturing with high substrate tolerance.
Patent CN105602922A reveals efficient amidase catalysis for gabapentin intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalytic routes.
Novel patent CN116102473B process for high-purity agrochemical intermediate. Reduces cost and waste for mesotrione synthesis supply chain.
Patent CN103998618A reveals enzymatic hydrolysis for high-purity chiral intermediates. Discover supply chain advantages and cost reduction strategies.
Patent CN104178469B reveals high-purity enzymatic route for Cilastatin intermediate. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN116622672A reveals high-efficiency carboxylesterase mutants for chiral acid production, offering cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN105439870A details solvent-free DCU recycling yielding high-purity cyclohexylamine. This process offers substantial cost reduction and supply chain reliability for global buyers.
Novel fulvestrant preparation method ensures 99.8% purity without column chromatography. Significant cost reduction and scalable supply chain for pharmaceutical intermediates.
Patent CN115536720A details a novel chemical synthesis for cholic acid intermediate A8, offering a virus-free, plant-based alternative to animal extraction with scalable manufacturing potential.
Patent CN110669020A reveals efficient Cyclen production. Reduces cost and improves supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN118056823A reveals a scalable route for high-purity Platinib intermediates. This process eliminates chromatography, ensuring cost reduction and supply reliability for pharmaceutical manufacturers.